Bookmark and Share
1,1,1,2-TETRABROMOETHANE (CID 61179) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(173)
 
 
Inactive(567)
 
 
Inconclusive(73)
 
 
Unspecified(4)
 
 
Top Targets:
7TM GPCR Srx(18)
 
 
7TM GPCR Srsx(15)
 
 
NR LBD PPAR(13)
 
 
 
NR LBD ER(9)
 
 
 
NR LBD AR(9)
 
 
 
BioAssay Types:
Confirmatory(319)
 
 
 
 
 
Screening(291)
 
 
Summary(24)
 
 
 
 
Literature(6)
 
 
BioActivity Types:
Potency(290)
 
 
 
 
 
IC50(8)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 609    Data Row: 817   Total Pages: 17   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID17389492]
Potency 1.9953qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory]aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681]
View
2
[SID144208385]
Ratio Potency (uM) 6.39295qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary [AID743228, Type: summary]heat shock protein beta-1 [Homo sapiens] [gi:4504517]
View
3
[SID144208385]
Potency-Replicate_1 6.393qHTS assay for small molecule activators of the heat shock response signaling pathway [AID743210, Type: confirmatory]heat shock protein beta-1 [Homo sapiens] [gi:4504517]
View
4
[SID144208385]
Potency-Replicate_1 7.1108qHTS assay for small molecule agonists of the p53 signaling pathway [AID651631, Type: confirmatory]Cellular tumor antigen p53 [gi:269849759]
View
5
[SID17389492]
Potency 7.9433Cell Viability - LYMP2-022 [AID987, Type: confirmatory]
View
6
[SID49731941]
Potency 9.2qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory]TDP1 protein [Homo sapiens] [gi:79154014]
View
7
[SID144208385]
Ratio Potency (uM) 10.0443qHTS assay for small molecule agonists of the p53 signaling pathway: Summary [AID720552, Type: summary]Cellular tumor antigen p53 [gi:269849759]
View
8
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-024 [AID988, Type: confirmatory]
View
9
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-010 [AID981, Type: confirmatory]
View
10
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-012 [AID982, Type: confirmatory]
View
11
[SID17389492]
Potency 12.5893Cell Viability - LYMP2-007 [AID979, Type: confirmatory]
View
12
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-020 [AID986, Type: confirmatory]
View
13
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-015 [AID971, Type: confirmatory]
View
14
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-017 [AID972, Type: confirmatory]
View
15
[SID17389492]
Potency 15.8489Cell Viability - LYMP2-006 [AID978, Type: confirmatory]
View
16
[SID17389492]
Potency 19.9526Cell Viability - LYMP2-021 [AID974, Type: confirmatory]
View
17
[SID17389492]
Potency 19.9526Cell Viability - LYMP2-023 [AID975, Type: confirmatory]
View
18
[SID144208385]
ER Potency (uM) 20.041qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary [AID743091, Type: summary]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
19
[SID144208385]
Potency-Replicate_1 22.4864qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen [AID743203, Type: confirmatory]
View
20
[SID17389492]
Potency 25.1189Cell Viability - LYMP2-013 [AID970, Type: confirmatory]
View
21
[SID17389492]
Potency 29.8493qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory]nuclear factor erythroid 2-related factor 2 isoform 1 [Homo sapiens] [gi:20149576]
View
22
[SID17389492]
Potency 31.6228Cell Viability - LYMP2-009 [AID968, Type: confirmatory]
View
23
[SID144208385]
Potency-Replicate_1 35.6386qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line [AID743080, Type: confirmatory]estrogen nuclear receptor alpha [Homo sapiens] [gi:348019627]
View
24
[SID17389492]
Potency 39.8107Cell Viability - LYMP2-011 [AID969, Type: confirmatory]
View
25
[SID17389492]
Potency 39.8107Cell Viability - LYMP2-008 [AID980, Type: confirmatory]
View
26
[SID17389492]
Potency 42.1632qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion [AID651758, Type: confirmatory]interleukin 8 [Homo sapiens] [gi:186368]
View
27
[SID17389492]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_6, Type: other]
View
28
[SID17389492]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_7, Type: other]
View
29
[SID17389492]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_4, Type: other]
View
30
[SID17389492]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_1, Type: other]
View
31
[SID17389492]
qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838_2, Type: other]
View
32
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_4, Type: other]
View
33
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_5, Type: other]
View
34
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_6, Type: other]
View
35
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_7, Type: other]
View
36
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_8, Type: other]
View
37
[SID17389492]
Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_79, Type: other]
View
38
[SID17389492]
Cell Viability Profiling of Human Lymphoblast Cell Lines [AID588812_80, Type: other]
View
39
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_75, Type: other]
View
40
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_76, Type: other]
View
41
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_77, Type: other]
View
42
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_78, Type: other]
View
43
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_79, Type: other]
View
44
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_80, Type: other]
View
45
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_69, Type: other]
View
46
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_70, Type: other]
View
47
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_71, Type: other]
View
48
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_72, Type: other]
View
49
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_73, Type: other]
View
50
[SID17389492]
Caspase-3/7 Activation Profiling of Human Lymphoblast Cell Lines [AID588813_74, Type: other]
View